Historical Stock Price
ETFs Holding ADVM »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
09/13/2021 $2.24 $2.37 $2.12 $2.27 3.08M
09/14/2021 $2.28 $2.29 $2.16 $2.17 1.54M
09/15/2021 $2.19 $2.21 $2.13 $2.17 1.70M
09/16/2021 $2.18 $2.25 $2.10 $2.23 2.27M
09/17/2021 $2.21 $2.42 $2.18 $2.31 11.94M
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. ADVM-022 is a single, in-office intravitreal injection gene therapy. ADVM-022 is being developed for the treatment of patients with chronic retinal diseases who respond to anti-vascular endothelial growth factor therapy, including wet age-related macular degeneration and diabetic macular edema. ADVM-022 utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette.
ADVM historical stock prices picture
Adverum Biotechnologies (ADVM) has the following price history information. Looking back at ADVM historical stock prices for the last five trading days, on September 13, 2021, ADVM opened at $2.24, traded as high as $2.37 and as low as $2.12, and closed at $2.27. Trading volume was a total of 3.08M shares. On September 14, 2021, ADVM opened at $2.28, traded as high as $2.29 and as low as $2.16, and closed at $2.17. Trading volume was a total of 1.54M shares. On September 15, 2021, ADVM opened at $2.19, traded as high as $2.21 and as low as $2.13, and closed at $2.17. Trading volume was a total of 1.70M shares. On September 16, 2021, ADVM opened at $2.18, traded as high as $2.25 and as low as $2.10, and closed at $2.23. Trading volume was a total of 2.27M shares. On September 17, 2021, ADVM opened at $2.21, traded as high as $2.42 and as low as $2.18, and closed at $2.31. Trading volume was a total of 11.94M shares.

ADVM Historical Stock Prices By Date:

ADVM historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adverum Biotechnologies shares, starting with a $10,000 purchase of ADVM, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/31/2014
End date: 09/17/2021
Start price/share: $27.99
End price/share: $2.31
Dividends collected/share: $0.00
Total return: -91.75%
Average Annual Total Return: -29.50%
Starting investment: $10,000.00
Ending investment: $825.14
Years: 7.14
Date Close
09/13/2021$2.27
09/14/2021$2.17
09/15/2021$2.17
09/16/2021$2.23
09/17/2021$2.31
ADVM is categorized under the Healthcare sector; below are some other companies in the same sector:

ADXS Historical Stock Prices
AEGR Historical Stock Prices
AEMD Historical Stock Prices
AERI Historical Stock Prices
AEZS Historical Stock Prices
AFAM Historical Stock Prices
AFFX Historical Stock Prices
AGEN Historical Stock Prices
AGIO Historical Stock Prices
AGLE Historical Stock Prices

Also explore: ADVM shares outstanding history

ADVM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.